West Pharmaceutical Services (WST) Other financing activities (2009 - 2024)

West Pharmaceutical Services has disclosed Other financing activities across 14 years of filings, most recently posting -$100000.0 for Q1 2024.

• Other financing activities for Q1 2024 came in at -$100000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was -$100000.0 (down 200.0% YoY), and the FY2022 annual result was $1.2 million, changed N/A from the prior year.
• Other financing activities came in at -$100000.0 for Q1 2024 at West Pharmaceutical Services, roughly flat from -$100000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $2.3 million in Q4 2020 to a low of -$100000.0 in Q4 2022.
• The 3-year median for Other financing activities is $200000.0 (2022), against an average of $680000.0.
• Peak annual rise in Other financing activities reached 387.5% in 2020, while the deepest fall reached 387.5% in 2020.
• West Pharmaceutical Services' Other financing activities stood at $2.3 million in 2020, then tumbled by 104.35% to -$100000.0 in 2022, then changed by 0.0% to -$100000.0 in 2024.
• The last three Other financing activities figures came in at -$100000.0 (Q1 2024), -$100000.0 (Q4 2022), and $200000.0 (Q2 2022), per Business Quant data.